Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort. [electronic resource]
Producer: 20210423Description: 1661-1670 p. digitalISSN:- 2045-7634
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemoradiotherapy -- methods
- Clinical Decision-Making
- Decision Support Techniques
- Dose Fractionation, Radiation
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Nasopharyngeal Carcinoma -- diagnosis
- Nasopharyngeal Neoplasms -- diagnosis
- Neoplasm Staging
- Nomograms
- Progression-Free Survival
- Radiotherapy, Intensity-Modulated
- Reproducibility of Results
- Retrospective Studies
- Risk Assessment -- methods
- Risk Factors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.